Trial Profile
A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Active-Referenced, Fixed-Dose Study Comparing the Efficacy and Safety of 3 Doses of Lu AA21004 in Acute Treatment of Adults With Generalized Anxiety Disorder.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Vortioxetine (Primary) ; Duloxetine
- Indications Generalised anxiety disorder
- Focus Registrational; Therapeutic Use
- Sponsors Takeda
- 22 May 2009 New trial record